My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Rs 67.01 Crore Sanctioned under Solar City Programme
Nov 22,2016

A total amount of Rs. 67.01 crore has been sanctioned for preparation of master plans, solar city cells, promotional activities and installation of renewable energy projects and an amount of Rs. 24.16 crore has been released, so far, under Solar City Programme. Out of 7 identified solar cities in Maharashtra, an amount of Rs. 7.74 crore has been sanctioned and an amount of Rs. 3.04 crore has been released for 6 solar cities.

 The details of sanctioned and release funds for approved solar cities are as follows:

 State-wise funds sanctioned and released to Solar Cities(Rs. in crore)

Sr. NoStates/UTsApproved Solar Cities Funds Sanctioned      Funds Released       1

Andhra Pradesh

Vijayawada

1.960.90Kakinada-- -- Narsapur Town0.50--2

Assam

Guwahati

0.450.08 Jorhat0.490.243

Arunachal Pradesh

Itanagar

0.470.164

Bihar

Gaya

-- -- 5

Chandigarh

Chandigarh

25.168.116

Chhattisgarh

Bilaspur

0.430.12Raipur0.430.127

Gujarat

Rajkot

0.930.35

Gandhinagar

0.500.14

 Surat

2.681.118

Goa

Panaji City

0.430.029

Haryana

Gurugram

0.470.07

Faridabad

0.880.2810

Himachal Pradesh

Shimla

2.931.52

Hamirpur

0.430.2711

Karnataka

 Mysore

2.020.85

Hubli-Dharwad

0.430.0212

Kerala

Thiruvananthapuram

----

Kochi

0.490.1913

Maharashtra

Nagpur

4.682.14Thane1.130.51Kalyan-Dombivli0.500.25Aurangabad0.500.08Nanded0.500.04Pune-- -- Shirdi0.430.0214

Madhya Pradesh

 Indore

----Gwalior0.500.10Bhopal 0.480.19Jabalpur-- -- Rewa 0.500.1415

Manipur

Imphal

0.490.0416

Mizoram

Aizawl

2.962.5317

Nagaland

Kohima

0.470.20 Dimapur 0.490.0418

Centrum Capital gets license to commence housing finance business
Nov 22,2016

Centrum Capital announced that it has received the Certificate of Registration from the National Housing Bank (NHB) to commence its Housing Finance business.

The Group has appointed Sanjay Shukla as MD & CEO of Centrum Housing Finance (CHFL) to lead the business, which is expected to commence operations in a couple of weeks.

Powered by Capital Market - Live News

L&T slips ahead of Q2 results
Nov 22,2016

Meanwhile, the BSE Sensex was up 48.21 points, or 0.19%, to 25,813.35.

On BSE, so far 1.05 lakh shares were traded in the counter, compared with average daily volume of 2.55 lakh shares in the past one quarter. The stock hit a high of Rs 1,360 and a low of Rs 1,306.60 so far during the day. The stock hit a 52-week high of Rs 1,615 on 27 July 2016. The stock hit a 52-week low of Rs 1,016.60 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 10.74% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 8.63% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 186.47 crore. Face value per share is Rs 2.

L&T announced during trading hours today, 22 November 2016, that its construction arm has won orders worth Rs 1926 crore across its various business segments.

L&Ts consolidated net profit rose 45.5% to Rs 609.60 crore on 9.3% growth in net sales to Rs 21718.61 crore in Q1 June 2016 over Q1 June 2015.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services. It operates in more than 30 countries worldwide.

Powered by Capital Market - Live News

Eastern Treads provides business update
Nov 22,2016

Eastern Treads announced that the Company has initiated state wise retreaders meet to educate and implement methodologies to realign with the recent likely changes due to currency demonetization and upcoming GST. The first such program was held in Kerala on 19 November 2016. Companys Kerala based franchisees have attended the program and discussed the impact of the currency demonetization and GST and the measures to be taken to ensure growth in this new regime.

Powered by Capital Market - Live News

Sobha hits 52-week low after poor Q2 result
Nov 22,2016

The result was announced after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 80.09 points, or 0.31%, to 25,845.23

On BSE, so far 9,547 shares were traded in the counter, compared with average daily volume of 13,180 shares in the past one quarter. The stock hit a high of Rs 234.05 so far during the day. The stock hit a low of Rs 224.05 in intraday trade so far, which is 52-week low for the counter. The stock hit a 52-week high of Rs 346 on 26 July 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 18.44% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, sliding 18.25% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 98.06 crore. Face value per share is Rs 10.

In Q2 September 2016, Sobha achieved new sales of 8.55 lakh square feet, valued at Rs 551 crore with an average realisation of Rs 6443 per square feet (Sobhas share of sale value stood at Rs 518 crore with an average realisation of Rs 6056 per square feet).

J.C. Sharma, Vice Chairman and Managing Director, Sobha said that the company has seen consistent improvement in cash flow and generated net positive operational cash flow for the past five consecutive quarters.

Sobha is a backward integrated real estate player. The company is primarily focused on residential and contractual projects.

Powered by Capital Market - Live News

Panacea Biotec gains over 3% in two sessions
Nov 22,2016

The announcement was made during market hours yesterday, 21 November 2016. Shares of Panacea Biotec rose 2.32% to Rs 107.95 on that day. The stock has risen 3.32% in two trading sessions from its close of Rs 105.50 on 18 November 2016.

Meanwhile, the BSE Sensex was up 100.04 points, or 0.39%, to 25,865.18.

On BSE, so far 2,493 shares were traded in the counter, compared with average daily volume of 14,290 shares in the past one quarter. The stock hit a high of Rs 111.85 and a low of Rs 108.60 so far during the day. The stock hit a 52-week high of Rs 171.20 on 4 December 2015. The stock hit a 52-week low of Rs 83.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, rising 0.47% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 1.51% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Rs 1.

Panacea Biotec has state-of-the-art pharmaceutical formulation facility located at Baddi for oral solids and oncology parenteral formulations. The company has been supplying products in US markets for approved abbreviated new drug applications (ANDAs) manufactured in oral solids dosage facility. A number of ANDAs submitted by the company, referring these facilities, are also at various stages of approval by the United States Food and Drug Administration (USFDA).

Panacea Biotec reported net loss of Rs 11.84 crore in Q2 September 2016, lower than net loss of Rs 17 crore in Q2 September 2015. Net sales declined 18.3% to Rs 131.56 crore in Q2 September 2016 over Q2 September 2015.

Panacea Biotec is one of Indias leading research based health management companies with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers in India and is one of the leading biotechnology companies.

Powered by Capital Market - Live News

Tata Communications forms partnership with Emirates Data Clearing House
Nov 22,2016

Tata Communications and Emirates Data Clearing House (EDCH), a regional leader in roaming solutions and seamless settlements announced a bilateral partnership for mutual business cooperation in their data and financial clearing forte offerings to mobile network operators across the globe.

This partnership will enable Tata Communications to provide a more robust portfolio of solutions as an integrated mobility service provider with its existing range of innovative solutions. EDCH will in turn expand their geographical avenues significantly towards global markets with an enhanced roaming and mobility management portfolio. The collaboration will allow both companies to enhance value and deliver a superior experience to new and existing customers.

Powered by Capital Market - Live News

Thomas Cook (India) opens Gold Circle Partner Outlet
Nov 22,2016

Thomas Cook (India) announced the opening of a new Gold Circle Partner Outlet in Bikaner. With this, the Companys network in Rajasthan extends to 10 locations across the State.

Powered by Capital Market - Live News

Vardhman Special Steels grants stock options
Nov 22,2016

Vardhman Special Steels announced that the Nomination and Remuneration Committee in its meeting held on 12 November 2016 has approved to grant 2,10,000 Employee Stock Options to the eligible employees under Vardhman Special Steels Limited Employee Stock Option Plan 2016, exercisable into not more than 2,10,000 fully paid-up equity shares in the Company in aggregate of face value of INR10 (Rupees Ten) each.

Further the Company has informed that, this is the First Grant under Vardhman Special Steels Limited Employee Stock Option Plan 2016.

Powered by Capital Market - Live News

Vedanta firms up ahead of board meeting
Nov 22,2016

Meanwhile, the BSE Sensex was up 119.70 points, or 0.46%, to 25,884.84.

On BSE, so far 4.06 lakh shares were traded in the counter, compared with average daily volume of 11.33 lakh shares in the past one quarter. The stock hit a high of Rs 204.85 and a low of Rs 199.10 so far during the day. The stock hit a 52-week high of Rs 233.65 on 10 November 2016. The stock hit a 52-week low of Rs 58.10 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, falling 3.10% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.15% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 296.47 crore. Face value per share is Re 1.

On a consolidated basis, Vedantas net profit rose 17.14% to Rs 1252.13 crore on 4.13% decline in net sales to Rs 15665.64 crore in Q2 September 2016 over Q2 September 2015.

Vedanta is a diversified natural resources company, whose business primarily involves producing oil & gas, zinc - lead - silver, copper, iron ore, aluminium and commercial power. The company has a presence across India, South Africa, Namibia, Australia and Ireland.

Powered by Capital Market - Live News

Suven Life Sciences in pink of health after securing two product patents
Nov 22,2016

The announcement was made during trading hours today, 22 November 2016.

Meanwhile, the BSE Sensex was up 99.64 points, or 0.39%, to 25,864.78

On BSE, so far 13,000 shares were traded in the counter, compared with average daily volume of 70,299 shares in the past one quarter. The stock hit a high of Rs 170 and a low of Rs 165.50 so far during the day. The stock hit a 52-week high of Rs 275.20 on 29 December 2015. The stock hit a 52-week low of Rs 144.35 on 19 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 16.28% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, sliding 16.32% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced the grant of one product patent from China and one product patent from Mexico corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2032 and 2031 respectively. The granted claims of the patents are from the mechanism of action include the class of selective H3 inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven Life Sciences said that the company has a total of twenty one granted patents from China and twenty two granted patents from Mexico. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts, the company said. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II, it added.

Suven Life Sciences net profit rose 58.2% to Rs 32.58 crore on 31.7% rise in net sales to Rs 133.23 crore in Q1 June 2016 over Q1 June 2015.

Suven Life Sciences is a biopharmaceutical company specializing in drug discovery and developmental activities in central nervous system disorders and contract research and manufacturing services (CRAMS).

Powered by Capital Market - Live News

Suven Life Sciences secures two product patents
Nov 22,2016

Suven Life Sciences announced the grant of one (1) product patent from China (CN 104540812) and one (1) product patent from Mexico (339858) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032 and 2031 respectively.

The granted claims of the patents are from the mechanism of action include the class of selective H3 Inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD),Huntingtons disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven has a total of twenty one (21) granted patents from China and twenty two (22) granted patents from Mexico. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinicaldevelopment like at Phase-I or Phase-II.

Powered by Capital Market - Live News

Asian Oilfield Services jumps after winning contracts from Oil India
Nov 22,2016

The announcement was made after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 178.26 points, or 0.69%, to 25,943.40.

On BSE, so far 72,000 shares were traded in the counter, compared with average daily volume of 97,910 shares in the past one quarter. The stock hit a 52-week high of Rs 89.80 on 25 October 2016. The stock hit a 52-week low of Rs 27.90 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 13.63% compared with the 8.23% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 2.49% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 22.32 crore. Face value per share is Rs 10.

Asian Oilfield Services said it received letters of award of two contracts by Oil India for acquisition of 2D Seismic Data in unappraised on land areas of North East India for an estimated total value of Rs 140 crore for both the contracts.

On a consolidated basis, Asian Oilfield Services reported net loss of Rs 11.12 crore in Q2 September 2016 as against net profit of Rs 4.09 crore in Q2 September 2015. Net sales declined 94.72% to Rs 3.09 crore in Q2 September 2016 over Q2 September 2015.

Asian Oilfield Services is engaged in providing geophysical, drilling and well services to customers across the Indian sub-continent.

Powered by Capital Market - Live News

L&T Construction secures new orders
Nov 22,2016

Larsen & Toubro announced that its construction arm has won orders worth Rs 1926 crore across various business segments as follows -

Power Transmission & Distribution Business - Rs 571 crore
Buildings & Factories Business - Rs 514 crore
Water & Effluent Treatment Business - Rs 397 crore
Metallurgical and Material Handling Business - Rs 298 crore
Heavy Civil Infrastructure Business - Rs 146 crore.

Powered by Capital Market - Live News

AXIS Bank gains on fund raising plan
Nov 22,2016

The announcement was made after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 232.51 points, or 0.90%, to 25,997.65.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 7.01 lakh shares in the past one quarter. The stock hit a high of Rs 471 and a low of Rs 467.90 so far during the day. The stock hit a 52-week high of Rs 638 on 7 September 2016. The stock hit a 52-week low of Rs 366.65 on 18 January 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 11.54% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 20% as against Sensexs 7.95% decline.

The large-cap private sector bank has equity capital of Rs 478.17 crore. Face value per share is Rs 2.

AXIS Bank said it proposes to raise funds by issuing unsecured redeemable non-convertible subordinated debentures (Basel- III compliant Tier II debentures) (Series - 25) of the face value of Rs 10 lakh each for cash at par aggregating to Rs 1800 crore. The board of directors of the bank will consider the proposal to issue and allot the above securities through circular resolution.

Axis Banks net profit declined 83.3% to Rs 319.08 crore on 14.1% growth in operating income to Rs 13698.77 crore in Q2 September 2016 over Q2 September 2015.

Axis Bank is one of the biggest private sector banks in India.

Powered by Capital Market - Live News